Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Clonally expanded CD8+ T cells cause alopecia areata.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Vitamin D helps treat psoriasis by promoting skin cell differentiation and reducing growth.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

ILC1-like cells can independently cause alopecia areata.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.